Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that it will report its first quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, May 13, 2021 at 4:30PM EDT.
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its first quarter 2021 financial results and provide an update on the cytisinicline development program on Thursday, May 13, 2021 at 4:30PM EDT.
To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 6096445. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.
Investor Relations Contact:
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4
Media Contact:
Glenn Silver
Glenn.Silver@Finnpartners.com
(646) 871-8485
SOURCE: Achieve Life Sciences, Inc.
View source version on accesswire.com:
https://www.accesswire.com/642534/Achieve-Life-Sciences-to-Announce-First-Quarter-2021-Financial-Results-and-Host-Conference-Call-and-Webcast-on-May-13-2021
